Please Wait

Applying Filters...

Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Octreotide Acetate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 27 USDMF, 9 CEP/COS, 4 JDMF, 8 EU WC, 1 KDMF, 21 NDC API, 33 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

64 Drugs in Development

64 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers, 61 FDA Orange Book, 201 Europe, 11 Canada, 48 Australia, 8 South Africa, 20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML, INJECTABLE;INJECTION - EQ 0.1MG BASE/ML, INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.5MG BASE/ML, INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 1 Gangwal Healthcare, 1 Pfanstiehl, 3 Kirsch Pharma, 2 Actylis, 1 BASF, 1 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 10 Direct Compression, 10 Taste Masking, 10 Parenteral, 7 Disintegrants & Superdisintegrants, 3 Co-Processed Excipients, 3 Granulation, 1 API Stability Enhancers, 1 Thickeners and Stabilizers, 1 Solubilizers, 1 Topical

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 42 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 59 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

20 APIs, 16 FDF Dossiers

PATENTS & EXCLUSIVITIES

29 US Patents, 1 US Exclusivities, 7 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 Others

6 Others

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
31/10/2025	Bachem AG	Switzerland	Bachem AG Bubendorf CH	R0-CEP 2020-229 - Rev 01	Octreotide	2022-07-18	Valid	Chemical		2414
31/10/2025	Auro Peptides Limited	India	AURO PEPTIDES LIMITED Kandi Mandal IN	CEP 2023-017 - Rev 00	Octreotide	2025-03-28	Valid	Chemical		2414

Contact us
to update this info

Octreotide Acetate

Octreotide Acetate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

61 API Suppliers

27 USDMF

9 CEP/COS

4 JDMF

8 EU WC

1 KDMF

21 NDC API

33 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

64 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers

61 FDA Orange Book

201 Europe

11 Canada

48 Australia

8 South Africa

20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML

INJECTABLE;INJECTION - EQ 0.1MG BASE/ML

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.5MG BASE/ML

INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

1 Gangwal Healthcare

1 Pfanstiehl

3 Kirsch Pharma

2 Actylis

1 BASF

1 Finar

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

1 Kerry

2 Microlex e.U

1 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

12 Chewable & Orodispersible Aids

10 Direct Compression

10 Taste Masking

10 Parenteral

7 Disintegrants & Superdisintegrants

3 Co-Processed Excipients

3 Granulation

1 API Stability Enhancers

1 Thickeners and Stabilizers

1 Solubilizers

1 Topical

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

42 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions

59 Regulatory FDF Prices

11 Annual Reports

MARKET PLACE

20 APIs

16 FDF Dossiers

PATENTS & EXCLUSIVITIES

29 US Patents

1 US Exclusivities

7 Health Canada Patents

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons